The Bipolar Spectrum in Psychiatric and General Medical Practice
Primary Psychiatry. 2004;11(9):30-35
• Bipolar disorder is more prevalent than previously believed.
• This higher prevalence is largely accounted for by a spectrum of bipolar disorders, which include bipolar type I, type II, and beyond.
• In different community studies, 5% of individuals on average are estimated to have bipolar spectrum disorders.
• Although counterintuitive, 30% to 70% of all depressions seen in various clinical settings, including both psychiatric and general medical practices, have been found to belong to the bipolar spectrum.
• The bipolar spectrum frequently presents clinically in association with panic, anxious-phobic, bulimic, addictive, and erratic personality disorders.
This introductory article examines the emerging scientific and clinical literature on bipolar types beyond those in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). These include new “softer” expressions of bipolarity, such as type II with briefer hypomanias, type II½, type III, and type IV. Patients within the soft spectrum beyond the DSM-IV prototypes are highly prevalent in private psychiatric, community mental health, and general medical practice. Thus, identifying bipolar disorder as a spectrum has clinically meaningful implications for comorbid conditions, the nature of a putative shared underlying pathophysiology, clinical management, and public health.
Until recently, it was believed that bipolar disorder occurred in 1% of the general population. This figure pertains to what is known as bipolar I disorder (manic-depressive illness). However, the current bipolar schema in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV),1 also includes bipolar II, cyclothymia, and bipolar not otherwise specified. Thus, it should not come as a surprise that, in a wave of new epidemiologic studies, the prevalence of the entire spectrum has been revised up to at least 5% of the general population.2 Although the DSM-IV does not use the construct of “bipolar spectrum,” its bipolar subtypes implicitly adhere to such a broad schema.
The work reviewed in this article examines the emerging scientific and clinical literature on bipolar types beyond DSM-IV bipolar I and II. These include new “softer” expressions of bipolarity, such as type II with briefer hypomanias, type II½ (depression superimposed on cyclothymia), type III (depression plus antidepressant-associated hypomania), and type IV (depression superimposed on a hyperthymic temperament).2,3
Patients within the soft spectrum beyond the DSM-IV prototypes are highly prevalent in psychiatric and primary care community and private practice settings. However, they often present clinically with a volatile mix of depression and biographical instability (ie, so-called erratic personality disorders), along with addictive, phobic-anxious, panic, and bulimic comorbidities. History of hypomania is more often than not overshadowed by the lifelong nature of these complex manifestations. It is important for psychiatrists, other mental health professionals, and general medical practitioners to be vigilant concerning the bipolar spectrum in patients presenting with the foregoing conditions. They should therefore conduct a diligent search for hypomania.
There is credible evidence that, depending on the study and the setting, somewhere between 30% and 70% of all depressions observed in clinical settings belong to this complex spectrum.2 The atheoretical position of the DSM-IV diagnostic system may serve as a blueprint for a research document, but regrettably it does not do justice to the clinical complexity of bipolarity as seen by the practitioner, nor does the DSM-IV provide any guidance on how to make sense of the conditions that accompany bipolar illness. Reformulating bipolar disorder as a spectrum has clinically meaningful implications for comorbidity, the nature of a putative shared underlying pathophysiology, clinical management, and public health.
Defining the Bipolar Spectrum
There is an emerging international consensus2 that bipolar disorder extends beyond the boundaries of an illness historically defined by an alternation of mania and depression. Indeed, between the extremes of full-blown manic-depressive illness (ie, bipolar I, where the patient has at least one acute manic episode) and strictly-defined unipolar depression (without personal or family history of mania or hypomania), there exists a prevalent spectrum of soft bipolar conditions with various admixtures of depression, hypomania, and temperamental instability.3
Those with spontaneous hypomania are now formally considered bipolar II in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision (DSM-IV-TR).4 Moreover, in many clinically depressed patients, elements of hypomanic activation can occur during an episode of major depressive disorder (MDD), resulting in “depressive mixed states” (which are not officially recognized in the DSM-IV). These patients pose diagnostic and therapeutic challenges for clinicians.3,5,6 Depressions with antidepressant-associated hypomania also appear, on the basis of extensive recent work,2,7 to be related to bipolar II (although some refer to them as bipolar III, also not an official rubric in the DSM-IV). Premorbid and interepisodic cyclothymic (a variant of bipolar II8) or hyperthymic traits (ie, bipolar type IV, consisting of overcheerful, overenergetic, and overconfident people who succumb to depression in their 40s and 50s9) represent prominent characteristics of other soft expressions of this spectrum. Patients across the soft spectrum may present with depression, anxiety, or mood swings. These mood swings are recurrent, biphasic, and abrupt, and are frequently induced by antidepressants (or stimulant and alcohol abuse) and/or by seasonal changes.3 Falling in and out of love and other excitements that could lead to sleep deprivation represent common contributory factors to the instability of these patients.3,9 Table 1 presents this proposed bipolar spectrum schema.
Although the DSM-IV-TR only includes bipolar types I and II, the aforementioned schema provides characterization for the remainder of the spectrum types, which in the DSM-IV are dubbed under the nondescript rubric of “bipolar not otherwise specified.” The proper specification of the entire spectrum is important for clinical practice. It makes little sense for a diagnostic manual developed for clinicians to categorize patients as having an unspecified disorder. Most physicians diagnose and manage conditions on the border of prototypical disorders. This is where the DSM-IV fails them. For a more in-depth description of this schema, the reader is referred to work by Akiskal and Pinto.9
Bipolar Disorder in Clinical and Community Settings
There has been a major recent research thrust in the study of bipolar disorder in its psychotic and ambulatory variants. It is now well accepted that mania can manifest in extreme psychotic forms,10 including “schizobipolar” phenotypes.11 Careful research has also delineated mixed or dysphoric forms of mania that also frequently reach psychotic proportions.12-17 Patients with such intense activation typically require psychiatric hospitalization. Current data indicate that at least two depressive symptoms exclusive of insomnia and agitation are sufficient for defining dysphoric mania. More provocatively, such mixed manic forms have been shown to arise from the baseline of a dysthymic (depressive) temperament, whereas pure mania is more typically superimposed on a hyperthymic temperament.
Current official systems of classification (such as the DSM-IV) are couched within the unipolar-bipolar distinction, yet a newer conceptual framework, in development since 1977,3,9,18-21 has accumulated data in favor of the existence of a prevalent group of intermediary, predominantly ambulatory, conditions. Recent studies in psychiatric settings,3,22-24 in general medical practice,25 and in the community26-29 have revealed a large spectrum of patients with soft or subtle signs of bipolarity. Bipolar II, the best known of these conditions, was first delineated by Dunner and colleagues.30 Typically these patients present with MDD, but upon expert interviewing31 reveal a history of activated behavior, mood lability, explosive behavior, or marked irritability.32 The soft bipolar spectrum, which is more prevalent than full-blown manic-depressive illness, constitutes a “clinical bridge” between unipolar and psychotic bipolar disorders,3 indicating the need for a partial return to Kraepelin’s33 broad concept of manic-depressive illness.
Based on the finding that depressive forms exceed definite bipolar cases in manic-depressive pedigrees by 4–5-fold,11 Akiskal and Mallya3 estimated in 1987 that the rates for the bipolar spectrum should be 4% to 5%. Epidemiologic studies have actually shown that these softer expressions of bipolarity have a prevalence range of 3.7% to 8.3%,26-29 as opposed to the conventionally reported rate of 1% for manic-depressive illness.34 Most interestingly, in private psychiatric, community mental health,2,3 and general medical25 settings, somewhere between 30% and 70% of patients presenting with MDD belong to the bipolar spectrum.
Focus on the Soft Spectrum
There are several intermediary conditions between bipolar I and strictly-defined unipolar MDD. The common feature of these intermediate bipolar conditions is the occurrence of manic activation at a subthreshold level.3,9 Bipolar II, the most prototypical of the soft bipolar spectrum, appears to be the most prevalent clinical expression of bipolar disorders.35 Spontaneous hypomania is needed for the diagnosis of bipolar II. Because bipolar II patients present clinically with depression and almost never with hypomania, the diagnosis of bipolar II requires skillful interviewing about history of such episodes. Current clinical guidelines2 indicate that the duration of hypomanic episodes is less important when numerous such episodes have occurred in the past. Hypomania is a distinct episode of mild elevation of mood, positive thinking, and increased activity level occurring over at least a few days. It is distinguished from ordinary happiness by the tendency of episodes to recur (happiness usually does not, unfortunately) and by the fact that it can be mobilized by antidepressants.3 Despite DSM-IV conventions to the contrary, the preponderance of evidence based on family history for bipolar disorder and clinical course2,7 indicates that hypomania during antidepressant treatment of an episode of MDD merits a bipolar designation (ie, bipolar III).
Individual hypomanic episodes may also be associated with positive emotions and creative thinking.36 However, the judgment of patients may be impaired. Repeated episodes of hypomania in association with mood swings may cumulatively contribute to the unstable course of bipolar II disorder, as well.2 Moreover, the experience of hypomania itself is often that of a “nervous high,” with marked irritable and hostile admixtures. According to the DSM-IV, hypomania typically presents without the marked impairment characteristic of manic episodes. Judging from the above symptoms of hypomania, however, the DSM-IV characterization of bipolar II as a milder condition is misleading. Table 2 provides a summary of findings on hypomanic episodes taken from clinical experience.3,9,18
Another characteristic of some, but not all, bipolar II patients is their labile cyclothymic temperamentality8 prior to and between MDD episodes.24 These patients, who can be considered “cyclothymic depressives,” exhibit a great deal more instability than bipolar II patients who present without cyclothymia; in fact, they are often mistaken for patients with borderline personality disorder. Prospective follow-up leading to MDD and/or hypomania rather than mania,18 and familial bipolar history, are the strongest evidence for the inclusion of these patients within the bipolar spectrum.8 One might consider them bipolar II variants or bipolar II½.9 The validated self-rated criteria for cyclothymia37 are summarized in Table 3. Patients with MDD endorsing at least six of these criteria are likely to belong to this bipolar variant.
In yet another soft bipolar subgroup, hypomanic and cyclothymic episodes as such are absent; instead, the individual has a persistent upbeat disposition, is overoptimistic, and functions at a high level of energy and confidence premorbidly and between depressive episodes. Unlike hypomania, which is an episode distinct from the patient’s habitual self, the hyperthymic traits of bipolar IV patients represent their habitual baseline.38 These traits have been found to define a subtype of MDD with bipolar family history indistinguishable from other disorders in the spectrum.9,22 The criteria for the hyperthymic temperament3 are summarized in Table 4. It is usually best to elicit these traits by clinical interview or from significant others; a patient with MDD meeting at least four of these criteria can be clinically assigned to bipolar type IV.
Evidence for the importance of temperamental attributes in defining bipolar spectrum subtypes has come from the National Institute of Mental Health Collaborative Study of Depression (CDS) database. As demonstrated in a 12-year prospective examination of bipolar switching in the CDS,39 trait attributes consisting of “mood-lability” and “energetic-activity” permit a more precise characterization of the bipolar spectrum than the hypomanic periods emphasized in the DSM-IV and the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10).40 To properly diagnose soft bipolar conditions, the clinician must therefore carefully assess lifelong cyclothymic (mood-labile) or hyperthymic (active-energetic) traits. MDD episodes often complicate the life course in these individuals, and during these episodes, their conditions would therefore warrant the additional diagnosis of bipolar spectrum disorders.
In official diagnostic systems, bipolarity is characterized by the presence of alternating manic (or hypomanic) and depressive phases. However, a more fundamental characteristic of bipolarity is the reversal of the basic temperament into its opposite episode.41 Research22,24 has actually shown that the MDD expression in bipolar II disorder commonly arises from cyclothymic temperament. On the other hand, bipolar I disorder, characterized by a predominance of manic attacks, is more likely to arise from a dysthymic or hyperthymic temperament and, in bipolar I, a hyperthymic baseline is typically limited to patients with a predominantly manic course. Thus, the biphasic disturbance in bipolar illness often consists of the development of episodes that can be considered opposite in polarity to that of the antecedent temperament.41
As a result, the depressive episodes of many patients with soft bipolarity arising from cyclothymic and/or hyperthymic baseline are often mixed in nature (ie, isolated hypomanic symptoms, such as psychomotor acceleration, flight of ideas, and intense sexual arousal, intrude into MDD).3,5,42 Clinicians, when confronted with activated (labile, aroused, hostile, or agitated) MDD patients in psychiatric or general medical settings, must first rule out a bipolar spectrum condition. The same is true for a proportion of major depressions with intense anxious-phobic arousal.43
Comorbidity Within the Bipolar Spectrum
Mixed bipolar depressive states are ignored in both the DSM-IV and the ICD-10. This failure to recognize the bipolar nature of the volatile mix of temperament, depression, and anxious-phobic features often gives rise to such misleading characterologic diagnoses as borderline, histrionic, psychopathic,18,44 or atypical depressions.45
In the offspring of bipolar patients, affective storms can be misconstrued as attention-deficit/hyperactivity disorder (ADHD) and/or conduct disorder.46-48 ADHD and bipolar are distinct disorders, yet they often coexist. Thus, if family history is bipolar, considering these patients as a special ADHD-bipolar subtype is justified. Although such overlap is most common in manic or mixed manic children, it is at times observed in adults across the bipolar spectrum.
Substance and alcohol abuse are particularly prevalent among soft bipolar conditions.18,49,50 They often represent an attempt to enhance the hyper periods (with stimulants), rather than an attempt to self-medicate during depressed periods.32 Often comorbid appetitive behaviors, such as bulimia,51 can also be considered to have relevance to the bipolar spectrum. McElroy and colleagues51 contend that other impulse-control disorders, such as kleptomania and gambling, might have affinities to the bipolar spectrum as well. This is not to say that addictive, bulimic, and impulse-control disorders are secondary to bipolarity. Their common coexistence with bipolar disorder raises the possibility of shared underlying neurobiologic mechanisms. This is analogous to the common coexistence of obesity, diabetes, and hypertension, which are all diseases in their own right that are linked by the metabolic syndrome.
Bipolar spectrum patients with prominent temperamental dysregulation also appear vulnerable to the cycling effect of antidepressants.18,52,53 The excesses of bipolar II patients and the associated circadian disruptions appear relevant to the irregular cycling so often encountered in ambulatory bipolar patients today. A soft bipolar diagnosis is crucial, precisely because these patients need protection from antidepressant monotherapy (eg, with mood-stabilizing anticonvulsants or atypical antidepressants).
Interestingly, current data also suggest an intriguing association between soft bipolar conditions, especially cyclothymic conditions, and artistic creativity. Individuals with hyperthymic temperament are also over-represented among prominent individuals in leadership positions.54 In the same vein, professional achievement is over-represented among healthy relatives of bipolar patients.55,56 Thus, high achievement in various professional domains, or family history for such achievement, in the patient presenting with clinical depression can be used as a clinical pointer in favor of soft bipolarity.
On a more clinical note, pointers toward bipolarity include certain course, episode, phenomenological, and familial characteristics listed in Table 5.3,9,19
Since bipolar spectrum was first proposed,18,19 the literature has been enriched by conceptual extensions, modifications, and/or research in favor of the spectrum of bipolarity.57-68 The material reviewed in this article refers to the phenomenology, course, and familial aspects of the spectrum. It is likely that genetic heterogeneity exists, underlying the bipolar spectrum.69-71 This does not rule out the possibility that biological commonalities may be shared by the spectrum.
Although the concept of bipolar spectrum has been criticized on methodologic grounds,72 the evidence reviewed herein has documented that the spectrum and its comorbidities are prevalent conditions in both psychiatric and general medical settings. In the differential diagnosis of depressive, anxious-phobic, and panic states, the clinician must consider bipolar II and its variants. Comorbidity is high with addictive, bulimic, and borderline conditions. Migraine73 can also coexist with soft bipolar disorders, as can other psychophysiological disorders61 beyond the scope of this review. This means that bipolarity can present clinically with the foregoing nonaffective features. Given emerging data on the link between bipolarity and suicidality,74 the recognition and proper management of the bipolar spectrum and its comorbidities is relevant to suicide prevention.75,76
The emerging literature on the bipolar spectrum is beginning to impact psychiatric practice worldwide,77 as well as pathophysiologic understanding of putative common temperamental and molecular genetic mechanisms underlying the spectrum and its comorbidities.78 The bipolar spectrum is also relevant to family and general medical practice,79-82 which represents the de facto field for prevalent affective disorders, ADHD, and substance and alcohol use disorders.
It has not been the purpose of this overview on the bipolar spectrum concept and its adjoining conditions to demolish the edifice of the diagnostic prototypes embodied in the DSM-IV. The clinician should use these prototypic descriptions as a guide to identify the most likely diagnosis that best fits a patient presenting with an elusive and complex array of affective manifestations subthreshold to the classical bipolar type. In adults, these manifestations are typically comorbid with anxious, migrainous, addictive, bulimic, and erratic personality disturbances. The DSM-IV provides no guidance as to why these disorders often coexist with bipolar illness, nor does it provide any rationale for prioritizing one diagnosis over another. To focus on the presenting condition exhorted by the DSM-IV, while sensible, is not necessarily always the best diagnostic solution. Because of its therapeutic and prognostic implications, it is important not to miss a bipolar spectrum diagnosis in the patients described in this review. Early age of onset, episodic or cyclic course, marked seasonality, mixity, and bipolar family history can serve as markers for a bipolar diathesis in such patients.
It is meaningful to consider that this illness, while operationally distinct from its commonly co-occurring disorders, may nonetheless share underlying neurobiologic mechanisms with them. This style of thinking is an incentive to contemporary molecular oligogenic studies in the field of bipolar and related disorders.78 This model postulates various combinations of shared genes among the adjoining disorders of bipolarity and the bipolar spectrum itself.
Taking these factors into account, the concept of the bipolar spectrum can serve to bridge practice, clinical research, and more basic research in psychiatry.83 In fact, spectrum concepts of mental illness may represent a promising alternative to the DSM-IV.84 PP
1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000;59(suppl 1):S5-S30.
3. Akiskal HS, Mallya G. Criteria for the “soft” bipolar spectrum: treatment implications. Psychopharmacol Bull. 1987;23(1):68-73.
4. Diagnostic and Statistical Manual of Mental Disorders. 4th ed text rev. Washington, DC: American Psychiatric Association; 2000.
5. Akiskal HS, Benazzi F. Family history validation of the bipolar nature of depressive mixed states. J Affect Disord. 2003;73(1-2):113-122.
6. Sato T, Bottlender R, Schroter A, Moller HJ. Frequency of manic symptoms during a depressive episode and unipolar ‘depressive mixed state’ as bipolar spectrum. Acta Psychiatr Scand. 2003;107(4):268-274.
7. Akiskal HS, Hantouche EG, Allilaire JF, et al. Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J Affect Disord. 2003;73(1-2):65-74.
8. Akiskal HS, Hantouche EG, Allilaire JF. Bipolar II with and without cyclothymic temperament: “dark” and “sunny” expressions of soft bipolarity. J Affect Disord. 2003;73(1-2):49-57.
9. Akiskal HS, Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am. 1999;22(3):517-534.
10. Akiskal HS, Puzantian VR. Psychotic forms of depression and mania. Psychiatr Clin North Am. 1979;2:419-439.
11. Gershon ES, Hamovit J, Guroff JJ, et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry. 1982;39(10):1157-1167.
12. Akiskal HS, Hantouche EG, Bourgeois ML, et al. Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). J Affect Disord. 1998;50(2-3):175-186.
13. Post RM, Rubinow DR, Uhde TW, et al. Dysphoric mania. Clinical and biological correlates. Arch Gen Psychiatry. 1989;46(4):353-358.
14. Dell’Osso L, Placidi GF, Nassi R, Freer P, Cassano GB, Akiskal HS. The manic-depressive mixed state: familial, temperamental and psychopathologic characteristics in 108 female inpatients. Eur Arch Psychiatry Clin Neurosci. 1991;240(4-5):234-239.
15. Bauer MS, Whybrow PC, Gyulai L, Gonnel J, Yeh HS. Testing definitions of dysphoric mania and hypomania: prevalence, clinical characteristics and inter-episode stability. J Affect Disord. 1994;32(3):201-211.
16. McElroy SL, Strakowski SM, Keck PE Jr, Tugrul KL, West SA, Lonczak HS. Differences and similarities in mixed and pure mania. Compr Psychiatry. 1995;36(3):187-194.
17. Perugi G, Akiskal HS, Micheli C, et al. Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases. J Affect Disord. 1997;43(3):169-180.
18. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am J Psychiatry. 1977;134(11):1227-1233.
19. Akiskal HS. The bipolar spectrum: new concepts in classification and diagnosis. In: Grinspoon L, ed. Psychiatry Update: The American Psychiatric Association Annual Review. Vol II. Washington, DC: American Psychiatric Press; 1983:271-292.
20. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmacol. 1996;16(2 suppl 1):4S-14S.
21. Akiskal HS. The bipolar spectrum—the shaping of a new paradigm in psychiatry. Curr Psychiatry Rep. 2002;4(1):1-3.
22. Cassano GB, Akiskal HS, Savino M, Musetti L, Perugi G. Proposed subtypes of bipolar II and related disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affect Disord. 1992;26(2):127-140.
23. Benazzi F. Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice. J Affect Disord. 1997;43(2):163-166.
24. Hantouche EG, Akiskal HS, Lancrenon S, et al. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord. 1998;50(2-3):163-173.
25. Manning JS, Haykal RF, Connor PD, Akiskal HS. On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr Psychiatry. 1997;38(2):102-108.
26. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998;50(2-3):143-151.
27. Szadoczky E, Papp Z, Vitrai J, Rihmer Z, Furedi J. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. J Affect Disord. 1998;50(2-3):153-162.
28. Judd LL, Akiskal HS. The clinical and public health relevance of current research on subthreshold depressive symptoms to elderly patients. Am J Geriatr Psychiatry. 2002;10(3):233-238.
29. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64(1):53-59.
30. Dunner DL, Gershon ES, Goodwin FK. Heritable factors in the severity of affective illness. Biol Psychiatry. 1976;11(1):31-42.
31. Dunner DL, Tay LK. Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr Psychiatry. 1993;34(5):303-307.
32. Benazzi F, Akiskal HS. Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania. J Affect Disord. 2003;73(1-2):33-38.
33. Kraepelin E. Manic-Depressive Insanity and Paranoia. Edinburgh, Scotland: Ayer Company Publishers; 1921.
34. Robins LN, Regier DA, eds. Psychiatric Disorders in America. New York, NY: Free Press; 1991.
35. Simpson SG, Folstein SE, Meyers DA, McMahon FJ, Brusco DM, DePaulo JR Jr. Bipolar II: the most common bipolar phenotype? Am J Psychiatry. 1993;150(6):901-903.
36. Jamison KR, Gerner RH, Hammen C, Padesky C. Clouds and silver linings: positive experiences associated with primary affective disorders. Am J Psychiatry. 1980;137(2):198-202.
37. Akiskal HS, Mendlowicz MV, Rapaport MH, Kelsoe JR, Gillin JC, Smith TL. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J Affect Disord. In press.
38. Akiskal HS. Delineating irritable and hyperthymic variants of the cyclothymic temperament. J Personal Disord. 1992;6:326-342.
39. Akiskal HS, Maser JD, Zeller PJ, et al. Switching from ‘unipolar’ to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry. 1995;52(2):114-123.
40. International Statistical Classification of Diseases and Related Health Problems. 10 rev. Geneva, Switzerland: World Health Organization; 1992.
41. Akiskal HS. The distinctive mixed states of bipolar I, II, and III. Clin Neuropharmacol. 1992;15(suppl 1 pt A):632A-633A.
42. Akiskal HS, Benazzi F. Delineating depressive mixed states: their therapeutic significance. Clin Approaches Bipolar Disord. 2003;2:41-47.
43. Perugi G, Toni C, Akiskal HS. Anxious-bipolar comorbidity. Diagnostic and treatment challenges. Psychiatr Clin North Am. 1999;22(3):565-583.
44. Deltito J, Martin L, Riefkohl J, et al. Do patients with borderline personality disorder belong to the bipolar spectrum? J Affect Disord. 2001;67(1-3):221-228.
45. Perugi G, Akiskal HS, Lattanzi L, et al. The high prevalence of “soft” bipolar (II) features in atypical depression. Compr Psychiatry. 1998;39(2):63-71.
46. Wilens TE, Biederman J, Wozniak J, Gunawardene S, Wong J, Monuteaux M. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biol Psychiatry. 2003;54(1):1-8.
47. Masi G, Toni C, Perugi G, et al. Externalizing disorders in consecutively referred children and adolescents with bipolar disorder. Compr Psychiatry. 2003;44(3):184-189.
48. Dilsaver SC, Henderson-Fuller S, Akiskal HS. Occult mood disorders in 104 consecutively presenting children referred for the treatment of attention-deficit/hyperactivity disorder in a community mental health clinic. J Clin Psychiatry. 2003;64(10):1170-1176.
49. Maremmani I, Pacini M, Lubrano S, Lovrecic M, Perugi G. Dual diagnosis heroin addicts. The clinical and therapeutic aspects. Heroin Add Relat Clin Probl. 2003;5:7-98.
50. Camacho A, Akiskal HS. Proposal for a bipolar stimulant spectrum. Temperament, diagnostic validation and therapeutic outcomes with mood stabilizers. J Affect Disord. In press.
51. McElroy SL, Keck PE Jr, Phillips KA. Kleptomania, compulsive buying, and binge-eating disorder. J Clin Psychiatry. 1995;56(suppl 4):14-26. Discussion in: J Clin Psychiatry. 1995;56(suppl 4):27
52. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol. 1980;13(4):156-167.
53. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry. 1987;144(11):1403-1411.
54. Akiskal HS, Akiskal K. Re-assessing the prevalence of bipolar disorders: clinical significance and artistic creativity. Psychiatrie Psychobiologie. 1998;3:29-36.
55. Coryell W, Endicott J, Keller M, et al. Bipolar affective disorder and high achievement: a familial association. Am J Psychiatry. 1989;146(8):983-988.
56. Richards R, Kinney DK, Lunde I, Benet M, Merzel AP. Creativity in manic-depressives, cyclothymes, their normal relatives, and control subjects. J Abnorm Psychol. 1988;97(3):281-288.
57. Taylor MA, Abrams R. Reassessing the bipolar-unipolar dichotomy. J Affect Disord. 1980;2(3):195-217.
58. Klerman GL. The spectrum of mania. Compr Psychiatry. 1981;22(1):11-20.
59. Egeland JA. Bipolarity: the iceberg of affective disorders? Compr Psychiatry. 1983;24(4):337-344.
60. Tsuang MT, Faraone SV, Fleming JA. Familial transmission of major affective disorders. Is there evidence supporting the distinction between unipolar and bipolar disorders? Br J Psychiatry. 1985;146:268-271.
61. Endicott NA. Psychophysiological correlates of ‘bipolarity’. J Affect Disord. 1989;17(1):47-56.
62. Himmelhoch JM. Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues. J Affect Disord. 1998;50(2-3):203-213.
63. Ghaemi SN, Ko JY, Goodwin FK. “Cade’s disease” and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry. 2002;47(2):125-134.
64. Angst J, Gamma A. A new bipolar spectrum concept: a brief review. Bipolar Disord. 2002;4(suppl 1):11-14.
65. Dunner DL. Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord. 2003;5(6):456-463.
66. Benazzi F. High frequency of bipolar spectrum in outpatients with depression. Can J Psychiatry. 2004;49(4):279-280.
67. Hirschfeld RM. Bipolar spectrum disorder: improving its recognition and diagnosis. J Clin Psychiatry. 2001;62(suppl 14):5-9.
68. Cassano GB, Rucci P, Frank E, et al. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry. 2004;161(7):1264-1269.
69. Gershon ES. Bipolar illness and schizophrenia as oligogenic diseases: implications for the future. Biol Psychiatry. 2000;47(3):240-244.
70. MacKinnon DF, Xu J, McMahon FJ, et al. Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. Am J Psychiatry. 1998;155(6):829-831.
71. Alda M. The phenotypic spectra of bipolar disorder. Eur Neuropsychopharmacol. 2004;14(suppl 2):S94-S99.
72. Baldessarini RJ. A plea for integrity of the bipolar disorder concept. Bipolar Disord. 2000;2(1):3-7.
73. Oedegaard KJ, Fasmer OB. Is migraine in unipolar depressed patients a bipolar spectrum trait? J Affect Disord. 2004.
74. Rihmer Z, Pestality P. Bipolar II disorder and suicidal behavior. Psychiatr Clin North Am. 1999;22(3):667-673.
75. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290(11):1467-1473.
76. Yerevanian BI, Koek RJ, Mintz J. Lithium, anticonvulsants and suicidal behavior in bipolar disorder. J Affect Disord. 2003;73(3):223-228.
77. Akiskal HS. Classification, diagnosis and boundaries of bipolar disorders. In: Maj M, Akiskal HS, Lopez-Ibor JJ, Sartorius N, eds. Bipolar Disorder. London, UK: John Wiley & Sons; 2002:1-52.
78. Kelsoe JR. Arguments for the genetic basis of the bipolar spectrum. J Affect Disord. 2003;73(1-2):183-197.
79. Manning JS, Conner PD, Sahai A. The bipolar spectrum. A review of current concepts and implications for the management of depression in primary care. Arch Fam Med. 1998;7:63-71.
80. Manning JS, Haykal RF, Akiskal HS. The role of bipolarity in depression in the family practice setting. Psychiatr Clin North Am. 1999;22(3):689-703.
81. Manning JS, Ahmed S, McGuire HC, Hay DP. Mood disorders in family practice: beyond unipolarity to bipolarity. Prim Care Companion J Clin Psychiatry. 2002;4(4):142-150.
82. Piver A, Yatham LN, Lam RW. Bipolar spectrum disorders. New perspectives. Can Fam Physician. 2002;48:896-904. Erratum in: Can Fam Physician. 2002;48:1190.
83. Akiskal HS. From dysthymia to the bipolar spectrum: bridging practice and research (Jean Delay Prize Paper). Paper presented at: XII World Congress of Psychiatry; August 24–29, 2002; Yokahama, Japan.
84. Maser JD, Akiskal HS. Spectrum concepts in major mental disorders. Psychiatr Clin North Am. 2002;25(4):xi-xiii.
Dr. Akiskal is director of the International Mood Center in the Department of Psychiatry at the University of California, and chief of the Mood Disorders Program in the Veterans Administration Healthcare System, both in San Diego.
Disclosure: Dr. Akiskal is a consultant for and is on the speaker’s bureaus of Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen, and Sanofi-Synthelabo.
Please direct all correspondence to: Hagop S. Akiskal, MD, University of California, San Diego, International Mood Center, Department of Psychiatry, 3350 La Jolla Village Dr, La Jolla, CA 92161-0603; Tel: 619-552-8585; Fax: 619-534-8598; E-mail: email@example.com.